Mechanism of Action

The newly designed nanoparticles incorporate features that enhance their movement and distribution within tumours:

1. Improved tumour infiltration
   The nanoparticles are engineered to move more effectively through tumour tissue, reaching areas that are typically difficult for drugs to access
2. Enhanced cellular uptake
   Surface modifications may allow better interaction with cancer cells, improving internalisation
3. Optimised physicochemical properties
   Adjustments in size, charge, and structure help facilitate deeper penetration and more uniform drug distribution

Research has shown that modifying nanoparticle characteristics—such as surface charge—can significantly influence their ability to penetrate tumours and increase drug bioavailability.

Key Findings from the Study

1. Improved Drug Penetration

The novel nanoparticle system demonstrated enhanced ability to penetrate tumour tissue compared to conventional delivery systems.

2. More Uniform Drug Distribution

The system enabled more even distribution of the therapeutic agent within the tumour, potentially addressing one of the major causes of treatment resistance.

3. Potential for Increased Treatment Effectiveness

By improving drug penetration, the approach may enhance overall therapeutic efficacy and reduce the likelihood of untreated tumour regions.

Why This Matters in Cancer Care

This research reflects a broader shift toward precision drug delivery in oncology.

Improving drug penetration may help:

• Increase treatment effectiveness in solid tumours
• Reduce drug resistance caused by uneven exposure
• Optimise the performance of existing cancer therapies
• Support combination strategies with chemotherapy, targeted therapy, or immunotherapy

Nanotechnology is increasingly recognised as a key tool in overcoming biological barriers in cancer treatment.

Limitations and Current Status

• The findings are currently based on preclinical research
• Further validation in human clinical trials is required
• Long-term safety and scalability remain to be established

While promising, this approach is not yet part of standard clinical practice.

Conclusion

The development of a novel nanoparticle system to enhance tumour penetration represents a significant advancement in cancer drug delivery.

By improving how drugs move within tumours—not just how they reach them—this strategy may help unlock the full potential of existing cancer therapies and contribute to more effective treatment outcomes.

References

• Drug Target Review. (2025). New nanoparticle enhances cancer drug penetration. https://www.drugtargetreview.com/new-nanoparticle-enhances-cancer-drug-penetration/656187.article
• Yao, Y., Zhou, Y., Liu, L., Xu, Y., Chen, Q., Wang, Y., Wu, S., Deng, Y., Zhang, J., & Shao, A. (2020). Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Frontiers in Molecular Biosciences, 7, 193.
• Sell, M. (2023). Application of nanoparticles in cancer treatment. International Journal of Molecular Sciences.
• Hoang, C. N. M., et al. (2025). Nanoparticles in cancer therapy: Strategies to penetrate and modulate the tumor microenvironment. Smart Materials in Medicine.
• Souri, M., et al. (2024). Charge-switchable nanoparticles to enhance tumor penetration and accumulation. European Journal of Pharmaceutical Sciences.